Leo Wealth’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.39M Buy
+9,718
New +$1.47M 0.29% 78
2026
Q1
$2.42M Sell
15,866
-562
-3% -$86.1K 0.18% 104
2025
Q4
$2.26M Buy
16,428
+3,148
+24% +$412K 0.16% 107
2025
Q3
$1.7M Sell
13,280
-3,100
-19% -$378K 0.22% 85
2025
Q2
$1.98M Buy
16,380
+2,210
+16% +$249K 0.15% 122
2025
Q1
$1.58M Buy
14,170
+2,297
+19% +$245K 0.23% 88
2024
Q4
$1.16M Sell
11,873
-2,066
-15% -$220K 0.1% 138
2024
Q3
$1.6M Buy
13,939
+1,047
+8% +$119K 0.15% 111
2024
Q2
$1.37M Buy
12,892
+3,488
+37% +$350K 0.14% 115
2024
Q1
$907K Sell
9,404
-578
-6% -$59.3K 0.09% 156
2023
Q4
$1.01M Buy
+9,982
New +$964K 0.1% 142

Other funds holding NVS

Leo Wealth's NVS Position: Q3 2026 in Review

Leo Wealth opened a new position in Novartis (NVS) in Q3 2026: 9,718 shares worth $1.39M. The stake represents 0.29% of the portfolio and ranks #78 among its holdings. This is a return to the name: Leo Wealth previously reported a position in NVS as recently as Q1 2026.

Leo Wealth first reported a position in NVS in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.42M in Q1 2026. 1,370 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • Leo Wealth held 9,718 shares of Novartis worth $1.39M as of Q3 2026.
  • Novartis was a new Leo Wealth position in Q3 2026.
  • Novartis made up 0.29% of Leo Wealth's portfolio in Q3 2026, its #78 holding.
  • Leo Wealth first reported a position in Novartis in Q4 2023 and has held it in 11 quarters since.
  • Leo Wealth's Novartis position peaked at $2.42M in Q1 2026.
  • 1,370 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on Leo Wealth's 13F filing for Q3 2026, filed 26 Oct 2026.